Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
Clinical trial results point to change in care of patients with high risk of metastatic recurrence
2021-06-03
(Press-News.org) New York, NY (June 2, 2021) - A phase 3 clinical trial co-led by Mount Sinai researchers is the first to show that immunotherapy after surgery to remove bladder cancer can reduce the risk of relapse for patients who are at high risk of their cancer returning in a deadly metastatic form, according to results published in The New England Journal of Medicine. The immunotherapy nivolumab was used as an adjuvant therapy, which is given after surgery in the hopes of maximizing its effectiveness.
The randomized trial, named "Checkmate 274," showed that using nivolumab increased these patients' chance of staying cancer free after surgery compared to patients who received a placebo. The average length of time before relapse nearly doubled in patients who received nivolumab, which is a monoclonal antibody immune checkpoint inhibitor that harnesses the immune system to fight cancer.
Surgery that removes the bladder or kidney and ureter is currently the standard of care for patients with urothelial cancer that has entered surrounding muscle or lymph nodes, though half of these patients later relapse with lethal metastatic cancer. Unfortunately for these patients, no consensus has emerged regarding treatments after surgery that might reduce the risk of cancer recurrence.
"These clinical trial results promise to impact standard treatment of patients with urothelial cancer of the kidney, ureter, or bladder by reducing the risk of metastatic recurrence after surgery," said Matthew Galsky, MD, senior author of the study and Director of Genitourinary Medical Oncology, Co-Director of the Center of Excellence for Bladder Cancer, Associate Director of Translational Research, and Co-Leader of the Cancer Clinical Investigation Program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. "Almost 200,000 people die each year of urothelial cancer worldwide, so advances like immunotherapy being used in this manner bring hope."
INFORMATION:
A total of 709 patients were part of the trial; half received nivolumab and the other half received placebo every two weeks for one year. The vast majority of patients who received nivolumab had no impact on their quality of life.
This trial was conducted with support from Bristol Myers Squibb, the maker of the immunotherapy, in collaboration with ONO Pharmaceutical Company Ltd.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care--from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.
For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-03
June 5, 2021 marks the 40th anniversary of the first report of AIDS cases and the onset of the American AIDS epidemic. In a new, thought-provoking paper in the New England Journal of Medicine, Professor Ronald Bayer and co-author Gerald Oppenheiner capture the experiences of the physicians who were central to the AIDS epidemic. In the words of the doctors, they relay what it meant to look back after 40 years and how they "aged together."
The doctors called their experiences extraordinary and the conditions demanding, under which they performed their duties and treated their patients. They speak of their work as "in the trenches," giving their careers immediate meaning and value that they never expected. As several physicians expressed, ...
2021-06-02
MINNEAPOLIS - Deep brain stimulation continues to be effective in people with Parkinson's disease 15 years after the device is implanted, according to a study published in the June 2, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers found that compared to before deep brain stimulation, study participants continued to experience significant improvement in motor symptoms, which are symptoms that affect movement, as well as a reduction in medications 15 years later.
Parkinson's disease can progressively affect speech, walking and balance due to a gradual reduction of a chemical in the brain called dopamine. Parkinson's symptoms of muscle stiffness, tremor and slowness ...
2021-06-02
MINNEAPOLIS - Older people with type 1 diabetes who have been to the hospital at some point for both low and high blood sugar levels may be at six times greater risk for developing dementia years later. The research is published in the June 2, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that people with type 1 diabetes who visit the hospital for just one of the blood sugar extremes may also be at greater risk for developing dementia.
Type 1 diabetes is a chronic condition in which the pancreas produces little or no insulin.
Hypoglycemia is low blood glucose, or the main sugar in blood, that may result in loss of consciousness. Hyperglycemia results from insulin deficiency or extremely ...
2021-06-02
URBANA, Ill. -When pigs get hit with significant illnesses during key stages of pregnancy, their immune response may negatively affect developing piglets, making them less productive on the farm. New research from the University of Illinois shows that when those piglets - especially males - experience a second stressor in early life, they are at higher risk of neurodevelopmental and other neurological anomalies, putting them at an even greater disadvantage in production settings.
"With more information about maternal illness, what we call maternal immune activation, we can make better decisions about how to handle these types of immune challenges within animal production settings," says Marissa Keever-Keigher, doctoral student ...
2021-06-02
In a new study, University of Maine researchers found that culture helps humans adapt to their environment and overcome challenges better and faster than genetics.
After conducting an extensive review of the literature and evidence of long-term human evolution, scientists Tim Waring and Zach Wood concluded that humans are experiencing a "special evolutionary transition" in which the importance of culture, such as learned knowledge, practices and skills, is surpassing the value of genes as the primary driver of human evolution.
Culture is an under-appreciated factor in human evolution, Waring ...
2021-06-02
Icebergs crumbling into the sea may be what first come to mind when imagining the most dramatic effects of global warming.
But new University of Arizona-led research, published in Geophysical Research Letters, suggests that more record-breaking temperatures will actually occur in the tropics, where there is a large and rapidly growing population.
"People recognize that polar warming is much faster than the mid-latitudes and tropics; that's a fact," said lead study author Xubin Zeng, director of the UArizona Climate Dynamics and Hydrometeorology Center and a professor of atmospheric sciences. "The second fact is that the warming over land is greater than over ...
2021-06-02
People of color are more than twice as likely to die after a traumatic brain injury as white people, according to a new retrospective review from Oregon Health & Science University.
The study published today in the journal Frontiers in Surgery.
In the report, "Racial and Ethnic Inequities in Mortality During Hospitalization for Traumatic Brain Injury: A Call to Action," the researchers analyzed more than a decade of data related to the health outcomes and demographics of thousands of patients treated for traumatic head injuries at OHSU Hospital, one of two Level 1 trauma centers in the state.
They found a clear delineation of worse outcomes for people of color.
"We have a societal and professional duty to recognize and accept that the effects of structural ...
2021-06-02
Hydrogels are commonly used inside the body to help in tissue regeneration and drug delivery. However, once inside, they can be challenging to control for optimal use. A team of researchers in the Department of Biomedical Engineering at Texas A&M University is developing a new way to manipulate the gel -- by using light.
Graduate student Patrick Lee and Dr. Akhilesh Gaharwar, associate professor, are developing a new class of hydrogels that can leverage light in a multitude of ways. Light is a particularly attractive source of energy as it can be confined to a predefined area as well as be finetuned by the time or intensity of light exposure. Their work was recently published in the journal Advanced Materials.
Light?responsive hydrogels are an ...
2021-06-02
OAKLAND, Calif. -- In patients with insulin-treated type 2 diabetes, the use of continuous glucose monitors is associated with better blood sugar control and fewer visits to the emergency room for hypoglycemia, a Kaiser Permanente study published June 2 in the journal JAMA found.
The monitors have previously been shown to improve glucose control for patients with type 1 diabetes. Continuous glucose monitors are now the standard of care for these patients.
"The improvement in blood sugar control was comparable to what a patient might experience after starting a new diabetes medication," said the study's lead author Andrew J. Karter, PhD, a senior research scientist with the Kaiser Permanente Northern California ...
2021-06-02
What The Study Did: Researchers investigated the effect of real-time continuous glucose monitoring on glycemic control among patients with insulin-treated diabetes.
Authors: Andrew J. Karter, Ph.D., of Kaiser Permanente in Oakland, California, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2021.6530)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
INFORMATION:
Media advisory: The full study and editorial ...
LAST 30 PRESS RELEASES:
[Press-News.org] Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
Clinical trial results point to change in care of patients with high risk of metastatic recurrence
